BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23271498)

  • 1. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
    Ljubin-Sternak S; Mestrovic T; Vilibic-Cavlek T; Mlinaric-Galinovic G; Sviben M; Markotic A; Skerk V
    Folia Microbiol (Praha); 2013 Sep; 58(5):361-5. PubMed ID: 23271498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
    Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
    Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature.
    Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V
    Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z; Rosenberg S; Soffer Y; Dan M
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin.
    Chiarini F; Mansi A; Tomao P; Gentile V; De Marco F; Brunori S; Wongher L; Di Silverio F
    J Chemother; 1994 Aug; 6(4):238-42. PubMed ID: 7830100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial.
    Tamarelle J; Penaud B; Tyssandier B; Guichoux E; de Barbeyrac B; Peuchant O;
    Clin Microbiol Infect; 2023 Aug; 29(8):1056-1062. PubMed ID: 37100225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
    Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
    J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study).
    Peuchant O; Lhomme E; Krêt M; Ghezzoul B; Roussillon C; Bébéar C; Perry F; de Barbeyrac B;
    Medicine (Baltimore); 2019 Feb; 98(7):e14572. PubMed ID: 30762806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection.
    Horner P
    Sex Transm Infect; 2006 Aug; 82(4):340-3. PubMed ID: 16877590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.
    Geisler WM; Uniyal A; Lee JY; Lensing SY; Johnson S; Perry RC; Kadrnka CM; Kerndt PR
    N Engl J Med; 2015 Dec; 373(26):2512-21. PubMed ID: 26699167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
    Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
    Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.
    Shima K; Klinger M; Solbach W; Rupp J
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2828-30. PubMed ID: 23478971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Population-Based Study to Compare Treatment Outcomes Among Women With Urogenital Chlamydial Infection in Washington State, 1992 to 2015.
    Khosropour CM; Bell TR; Hughes JP; Manhart LE; Golden MR
    Sex Transm Dis; 2018 May; 45(5):319-324. PubMed ID: 29465681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.